Is your child living with Congenital Hyperinsulinism?

Xeris Pharmaceuticals is currently seeking volunteers for a clinical research study for infants with Congenital Hyperinsulinism (HI).


See if your child may qualify:

In order to qualify, the participant must: 

  • Be diagnosed with Congenital Hyperinsulinism
  • Require intravenous glucose to prevent hypoglycemia
  • Be less than 12 months of age at screening

Are you considering treatment options?

The study is taking place in the following cities: Los Angeles, San Francisco, Houston, Ft. Worth, and St. Louis. Travel arrangements are available and can be organized for your family. All or part of the cost of travel for qualified volunteers may be covered by the study Sponsor.

For more information on participating in this study, call (844) 311-3330.

Fix the following errors: